WINDLAS closed at ₹1,126.35 on Sep 4, 2026. Windlas Biotech Limited (WINDLAS) trades on NSE/BSE. Market capitalisation is ₹2,324 Cr. The trailing P/E ratio is 35.63. It operates in the Healthcare sector.
WINDLAS, Upmazing Score 68/100
Windlas Biotech Limited (NSE: WINDLAS) scores 68 on Upmazing’s scoring engine, read from two independent layers: fundamentals filed with the exchange and end-of-day technicals. Below: each signal layer and the numbers behind it, marked with their sources.
Not built yetAI synthesis — not built yetOne paragraph that fuses WINDLAS's latest filings with its price structure. Not built yet — nothing behind this card generates it today.
Past EOD returns redistributed — not a projection. LTCG shown at 12.5% beyond the ₹1.25 L/yr exemption (FY26 rules), indicative only, not tax advice; SIP units have mixed holding periods.
Frequently asked
auto-built per stock · FAQ schema
Once WINDLAS's end-of-day history is ingested, this page shows its official exchange close, refreshed after each trading session, with the full price history on the Chart tab (split- and bonus-adjusted for NSE-primary series; BSE-primary series are shown as-traded). Upmazing does not stream live quotes, so every price-linked figure is anchored to the last close.
Where enough filed data exists, WINDLAS carries an Upmazing Score, a 0-100 standing computed from its real fundamentals (growth, margins, leverage, returns) and end-of-day technicals. The Score tab breaks down every component, and says plainly when one can't be computed.
After each session with price data on record, WINDLAS runs through Upmazing's end-of-day scanner library, covering momentum, trend, volatility, volume and fundamental checks. Scanners that fired on the latest session are listed on the Patterns tab with the exact rule each fired on.
Declared dividends, ex-dates and bonus or split history for WINDLAS come from corporate-action records and appear here as they are ingested. Dividend yield is computed on trailing-12-month dividends at the last close.
Comparable companies for WINDLAS are grouped by sector, then compared on revenue growth, ROE, ROCE, debt-to-equity and margins. The Peers tab shows the full side-by-side table, and where a sector is classified, the sector peers panel on this page links the largest sector-mates.
Market cap for WINDLAS is computed from shares outstanding in the filed balance sheet, priced at the last close, and refreshed after each session. Where the balance-sheet input or a last close is missing, the cell shows a dash rather than an estimate.
The trailing 52-week high and low for WINDLAS are derived from its end-of-day price history and appear in the key statistics on this page once a full year of sessions is on record. The full price chart lives on the Chart tab.
The filed balance sheet for WINDLAS is presented on the Financials tab; for non-lenders that includes debt-to-equity, while banks and NBFCs read leverage through banking ratios instead.
Where WINDLAS's shareholding pattern has been ingested, the Holdings tab tracks promoter, FII, mutual-fund, DII and public holding plus any promoter pledge, quarter by quarter from the disclosed filings.
Prices are official exchange end-of-day closes, refreshed after each trading session. Fundamentals, shareholding and corporate actions for WINDLAS are parsed from official filings — quarterly results, shareholding disclosures and corporate-action records — as they are published.
Filed results · standalone · audited·as of Q1 2026-27partial data
Frequently Asked Questions
What is Windlas Biotech Limited's share price today?
Windlas Biotech Limited (WINDLAS) closed at ₹1,126.35 on 2026-09-04.
Which sector does Windlas Biotech Limited belong to?
Windlas Biotech Limited is classified under sector 'Healthcare' / industry 'Pharmaceuticals & Biotechnology' per NSE's 4-tier classification.
What is Windlas Biotech Limited's PE ratio?
Windlas Biotech Limited's trailing PE ratio is 35.6x based on the latest filed earnings and market close.
